Sumitomo Chemical Co. Ltd. (TYO:4005) is looking to establish a new plant for the mass production of single-guide RNA, a…...
Please subscribe to read the full story.
Crispr-Cas9
Kyoto University’s CiRA and Takeda to Develop DMD Treatment Using Genome-editing Technology
A team of researchers from Kyoto University’s Center of iPS Cell Research and Application (CiRA), led by Assistant Professor Akitsu…...
Please subscribe to read the full story.
